INTRODUCTION
Endometriosis remains a prevalent gynepathology frequently associated with infertility and chronic pelvic pain affecting 6 to 10% of women of reproductive age (1) . Multiple origins of ectopic endometrial glands and stroma have been postulated, but surgical evaluation of peritoneal lesion distribution in most patients is consistent with implantation after retrograde menstruation (2) . Emerging evidence suggests that molecular alterations disrupting normal hormone responsiveness may attenuate progesterone-directed differentiation in the secretory endometrium of affected women, conferring displaced tissue fragments with an ability to resist apoptosis, evade peritoneal immune surveillance, invade mesothelial surfaces, and rapidly acquire a vascular supply (3) . Progressive accumulation of invasive implants is associated with a local sterile inflammatory response that further supports the growth of new and existing lesions, and contributes to molecular and ultrastructural dysregulation within the eutopic endometrium (4, 5) .
Despite enormous efforts to dissect the well-documented clinical heterogeneity in endometriosis presentations, there remains a clear need to define objective measures of disease activity that are causally related to the severity of patient symptoms and variability in treatment responses, that is, fertility preservation, pain reduction, and disease recurrence (6, 7) . The most widely adopted pathological classification framework developed by the American Society for Reproductive Medicine (ASRM) uses a weighted scoring index to summarize the visual appearance, distribution, depth of invasion, and extent of endometriotic foci and adhesions observed at the time of diagnosis. However, the absence of a dose-response relationship between visual staging and symptomatic pain, infertility, or postoperative outcomes has led many investigators to conclude that cell and molecular features may be more discriminating of complex symptomatology and poor clinical response than anatomic characteristics alone (8) . In contrast, the peritoneal inflammatory milieu has long been recognized as a relevant dimension of disease activity because localized accumulation of immune cells and their effectors is thought to directly mediate or exacerbate the pathologic effects of ectopic lesions (9) . Numerous cellular, protein, and metabolite markers of peritoneal inflammation have been associated with endometriosis in significant proportions of patients, and efforts are under way to incorporate these into noninvasive diagnostic tests (10) . Nonetheless, their relevance to disease management beyond empirical diagnosis remains unclear due, in part, to a continued reliance on morphologic subclassification of patient populations (for example, via ASRM staging criteria) to improve statistical discovery of new associations.
An alternative approach to identify pathogenic mechanisms in the absence of unambiguous criteria for disease stratification is to exploit comprehensive multivariate measurements of molecular markers to empirically identify recurrent patterns conserved among women with heterogeneous clinical assessments of pain, infertility, and recurrence. This multivariate paradigm is emerging as informative in other inflammatory disorders and is an attractive framework for building a robust molecular taxonomy of endometriosis to complement traditional clinical parameters. In contrast to strictly supervised univariate comparisons, unsupervised multivariate techniques use molecular covariation as empirical evidence for biological co-regulation, and thereby improve the detection of coherent "signatures" of underlying physiological mechanisms, particularly when available class memberships are of a probabilistic nature or subject to observational error. That is, when several molecules change in a coordinated manner in the same patient, and similar patterns emerge among multiple patients (even among patients who are otherwise clinically heterogeneous), this suggests that they are part of a common cellular communication network that can be decoded using bioinformatics and subsequently validated with targeted interventions.
An attendant advantage to molecular stratification is an explicit emphasis toward informed therapeutic interventions that directly target disease-specific pathways. Because first-line medical suppression of ovarian hormones ameliorates pain in a fraction of endometriosis patients and has no benefit on fertility outcomes, there is substantial interest to identify alternative targets that function independently of the endocrine axis and circumvent the morbid side effects that frequently limit long-term use of hormone modulators (2) . Although empirical inhibition of canonical inflammatory mediators such as tumor necrosis factor-a (TNF-a), cyclooxygenase-2 (COX-2), and peroxisome proliferator-activated receptor g (PPAR-g) reduces lesion burden in rodent and nonhuman primate models of endometriosis, results from observational and preclinical trials in humans modulating these mediators have been mixed (11) . Furthermore, the inability to accurately assess pain, infertility, and spontaneous recurrence in animal studies continues to confound their relevance to mitigating symptoms in women. Therefore, systematically prioritizing the role of canonical and new inflammatory targets on the basis of human studies where direct relationships to clinical measures are unambiguously established is a prerequisite to developing new and efficacious therapies.
Here, we investigated the hypothesis that molecular profiles of peritoneal inflammation associated with endometriosis contain informative measures of symptom severity, and therefore provide a biological rationale for prioritizing specific therapeutic interventions. We therefore characterized the native and cell-secreted concentrations of 50 inflammatory cytokines, chemokines, and growth factors within peritoneal aspirates collected from women seeking surgical treatment for a variety of endometriosis-related symptoms and anatomic presentations, and subsequently asked whether patients within molecular subpopulations exhibited specific characteristics of pain and infertility. Although a number of individual protein markers demonstrated significant variations with respect to conventional ASRM staging criteria, unsupervised stratification according to molecular profiles alone revealed a broader signature of pelvic inflammation that was strongly associated with invasive rectovaginal and ovarian lesions in conjunction with reduced patient gravidity (that is, cumulative pregnancies).
RESULTS
Cytokine profiling of peritoneal aspirates Demographic and clinical variables for the 77 premenopausal women presenting with pain, infertility, and/or suspected endometriosis recruited for this study are summarized in Table 1 . Disease-free controls (n = 20) were predominantly women seeking treatment for symptomatic leiomyomata and limited to patients not receiving any form of progestin-based therapy within 3 months of surgery. Patients with laparoscopically confirmed endometriosis were classified as "untreated" (n = 41) or "treated" (n = 16) according to a history of concurrent progestin-based hormonal therapy within 3 months of surgery. In addition to age, body mass index (BMI), and cycle length, untreated cases and controls were selectively enrolled to obtain near-equal proportions of follicular and luteal phase samples. The frequency of previous surgical interventions unrelated to endometriosis was likewise equivalent in all three groups. Consistent with previous epidemiological findings, a diagnosis of endometriosis was associated with significantly reduced gravidity and parity (that is, cumulative pregnancies and births, respectively), as well as an increased frequency of concurrently diagnosed infertility (12) . Severe dysmenorrhea and dyspareunia were reported in about two-thirds of enrolled cases independent of treatment status, whereas noncyclic pelvic pain was more frequent among untreated women. In contrast, infertility was reported in a single control patient, and only one-quarter of control patients reported one or more severe pain symptoms. The physical distribution of lesions, revised ASRM staging scores, and reoperation rate were comparable between untreated and treated endometriosis cases. Although peritoneal fluid volume and total protein concentrations were similar in all patient groups, total leukocyte concentrations were significantly elevated in both untreated and treated endometriosis patients (Table 1) , in agreement with localized immune cell recruitment described in previous reports (13) . The concentrations of 50 inflammatory cytokines, chemokines, and growth factors within corresponding peritoneal aspirates were determined via multiplex immunoassay as described in Materials and Methods. All assayed proteins were detected above background levels with the exception of interleukin-1a (IL-1a), TNF-b, and IL-17, whose variation below~1 pg/ml could not be quantified and were therefore excluded from subsequent analyses ( fig. S2 ). After correcting for multiple comparisons [Benjamini-Hochberg false discovery rate (FDR) < 0.05, Wilcoxon rank-sum test], 10 of the remaining 47 cytokines exhibited statistically significant associations with endometriosis in univariate pairwise contrasts between patient groups defined by treatment status or ASRM staging [ Fig. 1 and tables S1 and S2; endometriosis versus controls: IL-8, P = 0.0221; granulocyte colony-stimulating factor (G-CSF), P = 0.0284; IL-9, P = 0.0068; IL-1b, P = 0.0131; IL-4, P = 0.0193; stage III/IV versus controls: IL-8, P = 0.0009; MIF, P = 0.0135; RANTES, P = 0.0034; G-CSF, P = 0.0007; IL-4, P = 0.0002; IL-16, P = 0.0294; interferon-g (IFN-g), P = 0.0009; IL-1b, P = 0.0004; IL-9, P = 0.0113; TNF-a, P = 0 and 95% confidence intervals (CIs) (bars) are shown for each analyte together with unadjusted P values from corresponding pairwise comparisons. n.s., not significant. *P < 0.05; **P < 0.01; ***P < 0.001. † Not significant after correction for multiple comparisons.
or cycle-dependent variation after correcting for multiple comparisons (table S3) . Additional subgroup analyses revealed no significant associations between patient subpopulations defined according to symptom recurrence (primary versus secondary surgical intervention), lesion distribution (peritoneal, ovarian, or deep disease), and primary indication (pain versus infertility) (tables S4 to S6). Most of our findings confirm associations reported in independent cross-sectional studies using morphological staging of disease severity, with the frequency of replication roughly corresponding to the observed effect size (table S7) . Collectively, these profiles underscore the relationship between patient morbidity, local leukocyte accumulation, and variable elevation of secreted inflammatory factors associated with pelvic endometriosis.
Unsupervised multivariate analysis of peritoneal cytokine profiles
To circumvent the limitations associated with the visual staging of endometriosis and simultaneously focus our analysis on those cytokine markers exhibiting the greatest evidence for co-regulated expression, we pursued a fully unsupervised approach that leveraged the multivariate structure of aspirate profiles across our diverse patient population. To this end, we first applied a consensus-based strategy to naïvely stratify normalized cytokine profiles from untreated endometriosis patients into self-similar subpopulations across an ensemble of unsupervised solutions derived from nonnegative matrix factorization (NMF) (14) . NMF identified an optimal subdivision of two patient subpopulations over higher levels of stratification, which not only was statistically significant with respect to marker permutation (k = 2, P < 0.0001; k = 3, P = 0.47; k = 4, P = 0.08) but also remained optimal across reduced data sets constructed by sequentially eliminating markers on the basis of total variation ( fig. S3 ). About two-thirds (n = 28) of endometriosis samples were assigned to a class indistinguishable from control samples (C1), with the second class (C2) comprising samples exhibiting four or more markedly elevated markers. Cytokines that were differentially expressed (FDR < 0.05, Wilcoxon rank-sum test) between C1 and C2 subpopulations included 13 analytes (IL-8, RANTES, MIF, IL-6, MCP-1, G-CSF, MIG, HGF, IL-10, IL-16, IL-1ra, GROa, and IL-1b), each exhibiting strong covariation across all 41 samples ( Fig. 2A) . This collection of markers-hereinafter referred to as a "consensus" cytokine signature-thus represents robust molecular features defining the spectrum of inflammatory activation in a substantial fraction of endometriosis patients in this study. Among those 13 consensus cytokines identified in multivariate analysis, six cytokines were also statistically related with patient ASRM scores in univariate tests of association ( Fig. 1E and table S2 ). Those six cytokines jointly declared significant in both analyses simultaneously fulfill the requirements for strong covariation as well as correlation with morphologic presentation. Conversely, incomplete correspondence between the remaining univariate and multivariate associations reflects divergence in the underlying data, with four univariate associations (IL-4, IL-9, IFN-g, and TNF-a) exhibiting marginal covariation with the regulatory axis captured by the consensus signature.
Subsequent comparison of patient characteristics based on molecular class assignment revealed negligible differences in age, BMI, cycle phase, cycle length, or symptomatic disease recurrence between 0.1 1 10 100
Relative difference ± 95% CI 0.01 0.1 1 10 100 Odds ratio ± 95%CI I III II  II  II  II  II  III  III  III  III  III  I I I I  I I  I IV  IV  IV  IV  IV  IV  IV  IV  IV  IV  IV  IV  II  II  II  I endometriosis subgroups (P > 0.05, Wilcoxon rank-sum and Fisher's exact tests). However, median and total variation in aspirate volume was markedly reduced among the elevated cytokine patient subgroup {11.5 ml [interquartile range (IQR), 3.5 to 18.8 ml] versus 3.0 ml (IQR, 0.7 to 6.8 ml); P = 0.0091, Wilcoxon rank-sum test} despite equivalent concentrations of total protein and leukocytes ( fig. S4 ). Because normal peritoneal fluid exudation by the ovaries and serous membranes is compromised in patients with substantial lesion burden (15) , elevated concentrations in these low volume samples may reflect a reduced capacity for homeostatic cytokine resorption and clearance afforded by a larger fluid interface with surrounding tissues. Furthermore, physical sequestration of fluid around complex lesions and adhesions that might contribute to incomplete fluid recovery would not be anticipated to modulate soluble concentrations of cytokines consistently. Consistent with this interpretation, elevated cytokines and reduced fluid volume were more frequently associated with lesions affecting the rectovaginal cul-de-sac ( Fig. 2B ; OR, 23.14; P = 0.0022, Fisher's exact test) and ovaries (OR, 4.8; P = 0.0376, Fisher's exact test). A similar degree of association with pelvic adhesions did not reach significance; however, elevated cytokines were less likely to be found among women presenting exclusively with peritoneal lesions versus those with multifocal implants (OR, 0.1231; P = 0.0239, Fisher's exact test). Although symptomatic pain was reported more frequently among endometriosis patients versus controls, a proportional association between elevated consensus markers and severe pain did not reach significance, regardless of site or context (Fig. 2B) . These data reinforce previous findings demonstrating partial correspondence between elevated cytokine concentrations and severity of pain (16, 17) . Increased consensus cytokine concentrations, however, were observed more frequently among nulligravid (that is, never pregnant) women (OR, 6.0; P = 0.0203, Fisher's exact test) and were more discriminating of patient gravidity than ASRM staging alone (stage I/II versus stage III/IV: OR, 2.444; P = 0.2146, Fisher's exact test). This decrease could not be explained by a previous diagnosis of infertility, because the proportion of clinically diagnosed infertile patients was equivalent in both subpopulations. Parity was likewise equivalent between patient groups, suggesting that endometriosis-associated inflammation may markedly impair successful conception but has a more limited influence on successful gestation.
Enrichment analysis of consensus cytokine markers
Having established a consensus signature of inflammatory factors distinguishing severe presentations of endometriosis associated with reduced fertility, we next investigated cellular mediators of this signature via systematic enrichment analysis. Although comprehensive secretomic profiles for representative peritoneal cell populations are currently unavailable, we reasoned that variations in cytokine transcript abundance might sufficiently capture relative propensities for protein production and secretion (18) . To this end, we mined the Immune Response In Silico (IRIS) transcriptional compendia (19) using Gene Set Enrichment Analysis (GSEA) to identify canonical leukocyte phenotypes enriched for expression of consensus cytokines or their cognate receptors as relevant secreting and responding populations, respectively. In contrast to similar compendia of resting immune cell populations (for example, ImmGen and Differentiation Map) or cell lines established from hematological malignancies (for example, Lymphochip), the IRIS compendia specifically incorporate profiles from diverse leukocyte populations under both resting and stimulated experimental conditions, where stimulants include a diverse assortment of model antigens, polarizing cytokines, and growth factors with canonical roles in both acute and chronic inflammation. This breadth of inflammatory phenotypes thereby strengthens our ability to make accurate inferences regarding lineage-specific contributions in endometriosis-associated inflammation.
As anticipated, differentiated myeloid lineages (that is, macrophages, dendritic cells, and neutrophils) demonstrated the greatest positive enrichment for consensus cytokine transcripts, whereas undifferentiated monocytes, dendritic cells, and neutrophils represented dominant responding populations (Fig. 3A) . Extending this approach to identify specific routes of intercellular communication in which consensus cytokine-receptor interactions were overrepresented, we computed pairwise enrichment scores between each major lineage in the IRIS compendia to examine the overall topology of the cytokine signaling network (Fig. 3B) . Although this later analysis excludes contributions from peritoneal tissues or ectopic lesions, the inferred hierarchical structure reinforces a model of macrophage activation as the locus of cytokine production and cell recruitment among the peritoneal immune cell populations.
To explicitly confirm that activated macrophages were a primary source of consensus cytokines in our study population, we subsequently quantified the concentration, proportion, and secretion status of CD68 + cells in a subset of aspirate samples from control and endometriosis patients (Fig. 3, C to E) . In addition to an overall increase in macrophage concentration and proportion among all patients, an increasing trend in both measures was observed when samples were grouped according to C1/C2 membership (linear trend test, P = 0.0148 and P = 0.0007, respectively), indicating further concordance between macrophage accumulation and increased cytokine abundance in peritoneal fluid. When cultured ex vivo, macrophages isolated from endometriosis patients spontaneously produced a marked abundance of 13 cytokines relative to controls (P < 0.05, Wilcoxon rank-sum test, more than twofold increase) (Fig. 3E and fig. S6 ). These included 8 of the 13 consensus markers (IL-1b, IL-1ra, IL-6, IL-8, IL-10, G-CSF, MCP-1, and RANTES), demonstrating that locally recruited macrophages are an important, if not primary, source of elevated cytokines observed within native peritoneal fluid.
Genome-wide inference of a macrophage coexpression network in endometriosis Although reference compendia composed of exogenously stimulated leukocyte populations such as IRIS provide a limited approximation to peritoneal immune cell activation in vivo, we hypothesized that global coexpression patterns therein might be sufficiently conserved to accurately infer the relevance of genes beyond those 50 cytokine markers assayed in peritoneal fluid and conditioned medium specimens. To further explore candidate coexpression partners relevant to the macrophage inflammatory response in endometriosis, we reordered transcripts in the IRIS compendia according to their median correlation distance to the 13 cytokines differentially secreted by isolated macrophages in vitro (Fig. 4A) . As anticipated, the macrophage secretion signature collectively ranked very high within this ordering, along with canonical macrophage surface markers such as CD14, CD68, and human leukocyte antigen (HLA)-A/B/C. Moreover, numerous gene products previously associated with endometriosis in independent studies were observed within the top 10% of genes in the coexpression profile, including IL-23, soluble TNF receptors I and II, MIP-3b (macrophage inflammatory protein 3b)/CCL19, ENA-78/CXCL5 (table S7) , MMP-9 (matrix metalloproteinase-9) (20), CCR1 (21), C3 (22) , NFkB (nuclear factor kB) (23), and COX-1/2 (24) . To verify that these inferences were not unique to the expression structure present in IRIS, we examined a second coexpression profile derived from the Human Immune Cell Transcriptome (HICT) compendia (25) , which demonstrated broad correspondence with IRIS profile rankings (P < 10
, Spearman correlation) and comparable enrichment of the independently validated inflammatory markers noted above among the top 10% of proximal coexpression partners.
Extending this approach to pathway-level analysis, we next applied GSEA to discern biological processes most strongly enriched among the inferred IRIS and HICT coexpression profiles. From 1320 annotated gene sets represented in the Canonical Pathways collection of MSigDB v4.0, we identified 60 up-and down-regulated gene sets coordinately enriched in both profiles (FDR < 0.01) (Fig. 4B) . In addition to nominal annotations corresponding to cytokine/receptor gene families, the top-scoring members of this subset included well-known processes associated with classical macrophage activation [for example, NOD (nucleotide-binding oligomerization domain)-like receptor signaling and antigen cross-presentation] and scavenger function (for example, proteasome, lysosome, and iron uptake pathways). Thus, reconstructing the coexpression network most closely related to the macrophage secretory signature not only implicates cellular processes relevant to endometriosis but also simultaneously prioritizes their constituent gene products for further investigation as potential therapeutic targets.
Validation of predicted transcriptional regulators in activated peritoneal macrophages Provided the ability to associate the observed macrophage secretory signature with defined molecular and cellular processes, we narrowed our analysis to exclusively consider individual transcriptional regulatory factors that contribute to the sustained production of inflammatory cytokines represented in the macrophage secretion signature. We first examined overrepresentation of transcriptional regulatory binding motifs among the measured cytokine signature, and subsequently confirmed positive enrichment among inferred IRIS and HICT profiles. Although we expect the former analysis to have modest statistical power given the limited number of protein measurements, the use of the genome-wide profiles provides a more robust assessment of overrepresentation under the assumption that changes in transcript levels primarily reflect the activity of specific regulators. From 244 annotated binding sequences within the promoter regions of the 50 assayed cytokines, 62 binding motifs corresponding to 10 transcription factors-C/EBPb (CCAAT/enhancer binding protein b), RelA, CREB-1, NFkB-RelA, ATF-2 (activating transcription factor 2), NFkB, c-Fos-c-Jun, c-Ets-1, AP-1 (activating protein 1), and STAT1 (signal transducer and activator of transcription 1)-were significantly overrepresented (P < 0.05, Fisher's exact test) among the 13 differentially secreted cytokines (table S8 and Fig. 3E ). Gene sets sharing the specific binding motifs for RelA, NFkB, c-Ets-1, and AP-1 were likewise enriched among the inferred IRIS and HICT coexpression profiles (Table 2) , adding additional evidence to their role in mediating the observed secretory signature.
Although the implied role for RelA and NFkB activity in macrophage cytokine secretion was largely unsurprising, the similar level of evidence supporting overrepresentation of binding motifs involving c-Jun (that is, AP-1 and ATF-2) was less anticipated and suggested an alternative avenue to limit the secretory activity of peritoneal macrophages. To directly test the predicted efficacy in inhibiting transcriptional activity of c-Jun and its AP-1 binding partner c-Fos, we evaluated the aggregate inhibition of the macrophage secretion signature in the presence of smallmolecule inhibitors targeting c-Jun N-terminal kinase (JNK), mitogenactivated protein kinase kinase 1 (MEK1), and IkB kinase (IKK) (Fig. 5,  A and B) . We simultaneously evaluated the inhibitory effects on four unrelated targets, whose downstream transcriptional regulators demonstrated partial [p38 and Janus kinase (JAK)] or negligible [SRC, protein kinase C (PKC), and phosphatidylinositol 3-kinase (PI3K)] enrichment in our analysis of promoter binding motifs.
Surprisingly, JNK and MEK1 inhibition mediated a comprehensive reduction in cytokine secretion on par with targeting IKK (56 and 68% versus 67% average secretion relative to vehicle, respectively) with no activating effects. In contrast, inhibitors targeting JAK1 and p38 demonstrated variably reduced secretion of some, but not all, 13 signature cytokines and, in the case of p38, markedly potentiated the production of MCP-1. Inhibitors targeting SRC, PKC, and PI3K likewise mediated a combination of inhibiting and potentiating secretion responses, with the aggregate effect proving modest to negligible (88 to 104% average secretion). Thus, the predicted role for transcriptional regulation of macrophage cytokine secretion extends beyond processes contributing to canonical NFkB signaling, highlighting an alternate route to blunting the inflammatory response for therapeutic effect.
DISCUSSION
Improving clinical stratification of women with surgically documented endometriosis on the basis of disease mechanisms remains a major hurdle to understanding and treating this heterogeneous disorder. Basic and clinical research efforts to develop evidence-based recommendations to improve clinical management of endometriosis presently confront simultaneous challenges associated with (i) sampling representative patient populations with divergent manifestations of endometriosis; (ii) characterization of patient specimens with partially or nonstandardized anatomic, pathological, and biochemical methods; and (iii) logistical considerations precluding prospective longitudinal studies to chronicle the natural course of disease. Although daunting, these challenges are not unique to endometriosis, and hence, there is enormous potential to translate insights from other clinical investigations into the strengths and limits of molecular stratification as a complement to conventional clinical parameters. The absolute degree to which common pathogenic mechanisms are shared among women with endometriosis-and therefore justify targeted therapeutic intervention in well-defined patient subpopulationsis currently unknown. Beyond the dynamic changes that accompany implantation, growth, and fibrosis of individual lesions, a significant proportion of patients harbor lesions of varying maturity, indicating that the local and systemic consequences of lesion progression reflect a mosaic of pathologic processes. Results from genome-wide and focused association studies of recurrent somatic variants further support the hypothesis that endometriosis is polygenic in nature and likely results from a combination of genetic susceptibility and environmental interactions (26) . Thus, as in other complex inflammatory disorders such as asthma, inflammatory bowel disease, and rheumatoid arthritis, substantial intra-and interindividual heterogeneity poses a severe challenge to the prognostic utility of low-dimensional indices summarizing clinicopathological features. These considerations strongly motivate empirical data-driven studies to identify multivariate features that provide optimal discrimination and robust generalization among larger populations. The rapid expansion of genomic annotations derived from complementary experimental profiles likewise facilitates a rich interpretation of multivariate signatures via enrichment and integrated network inference methodologies (27) . Together, tackling the intrinsic heterogeneity of complex disease processes at the cell and molecular level offers a tractable framework for building principled hypotheses and avoiding ad hoc biological interpretations.
In an effort to address these challenges, we identified a conserved set of inflammatory cytokine markers that maximally differentiated nascent and complex presentations of endometriosis, the latter associated with reduced patient fertility. In contrast to previous studies relying exclusively on morphologic criteria, this "consensus signature" of peritoneal inflammation derives from an unsupervised multivariate stratification of patient specimens according to shared molecular patterns of dysregulation within the peritoneal compartment. We subsequently applied an integrative enrichment analysis leveraging annotated transcriptional profiles to identify cellular mediators that were responsible for this observed signature, and validated activated macrophage populations as a dominant source of these secreted factors. Finally, reconstruction of a proximal coexpression network around macrophagesecreted cytokines implicated a well-defined subset of transcriptional binding sequences and associated regulatory factors (including c-Jun and NFkB), whose predicted activity was directly confirmed via pharmacologic inhibition. Although these results warrant further investigation, they provide additional proof of principle for the utility of cytokine profiling as a means to broadly interrogate the immune cell-mediated response to complex pathologies, including endometriosis. Pending further validation among independent patient populations, the specific signatures described herein may also have direct clinical application for improving diagnostic classification and prospectively identifying women with a high likelihood to benefit from postoperative immune modulation in the course of pain remediation or fertility preservation (7) .
By adopting an unsupervised multivariate analysis, we explicitly accommodated the strong pattern of covariation between cytokines observed across endometriosis patients. Parallel enrichment and coexpression analyses using the univariate cytokine signature distinguishing ASRM III/IV patients from controls (Fig. 1B) failed to predict significant macrophage enrichment using GSEA, despite significant trends toward increased macrophage prevalence and abundance in advanced-stage patients ( fig. S7) . Furthermore, inferred coexpression profiles derived from the ASRM III/IV associations were markedly dissimilar from those derived using the consensus signature and resulted in far less coherent enrichment of related cellular pathways ( fig. S8) . Collectively, these disjointed inferences highlight the distinctive advantage in deriving a molecular signature in a multivariate fashion, which retains covarying markers that likely represent a common underlying regulatory program.
A critical finding from our unsupervised analysis is that marked variation in peritoneal fluid cytokine concentrations is attributable to a combination of reduced peritoneal fluid production and retention, together with increased macrophage abundance. Whether local accumulation of macrophages and their inflammatory markers represents a cause or consequence of reduced fluid levels is unclear, but our preliminary findings that both occur in subsets of patients with stage I/II and III/IV disease suggest an underlying phenomenon that may directly correspond to the severity of pain and infertility symptoms. A related finding with implications for diagnostic applications was the statistically significant but modest absolute deviation in a number of canonical inflammatory markers between patient subpopulations, that is, TNF-a, IL-1b, and IFN-g. Although central in importance to immune cell function and differentiation, the limited overall variation between patient populations suggests that such tightly regulated markers may prove suboptimal for empirical patient classification alone.
More strategic choices for molecular stratification will include downstream effectors such as chemokines (for example, IL-8, RANTES, and MCP-1) that exhibit substantial dynamic range within the peritoneal cavity.
We were unable to identify additional associations distinguishing patient subpopulations stratified according to duration of symptoms (initial versus secondary treatment), lesion distribution (peritoneal, ovarian, or deep disease), or surgical indication (pain versus infertility). Although this may be a consequence of small or unbalanced samples across distinct disease subgroups, the absence of additional molecular subpopulations may also reflect the high degree of overlapping disease characteristics that were present in most of the cases. Future observational studies designed to selectively characterize patient subpopulations with truly homogeneous disease characteristics will be of great value to address whether such subpopulations represent wholly distinct pathological entities.
To circumvent ad hoc biological interpretation of the observed molecular associations with endometriosis, we performed systematic enrichment analyses that leverage annotated genome-scale compendia to integrate the relative degrees of evidence from individual protein markers. Although this methodology relies on transcriptional variation as a proxy for protein level expression, the general framework may serve as a useful tool for protein-based profiling studies until proteomic compendia become available. We extended this approach to examine transcriptional coexpression patterns among two representative collections of resting and activated immune populations to infer (i) probable members of the inflammatory milieu not characterized in our immunoassay panel and (ii) candidate regulators of the inflammatory signature as potential avenues for therapeutic intervention. One insight from this analysis that has not been previously appreciated-JNK/c-Jun transcriptional activity-was validated as a potent regulatory element contributing to peritoneal macrophage cytokine production. Intriguingly, this insight resonates with recent animal studies, demonstrating the potent efficacy of JNK inhibition of cytokine production in a murine xenograft model of endometriosis that accompanied a marked reduction in lesion burden (28, 29) . We have also linked JNK-mediated signaling as an integral compensatory pathway regulating proteolytic cascades governing human endometriotic cell motility (30) . Future studies will examine this pathway in greater detail to clarify the mechanistic origins of upstream activation and evaluate complementary inhibitory agents as a therapeutic strategy to suppress peritoneal inflammation.
The origins of macrophage-driven peritoneal inflammation in endometriosis have been variably ascribed to autoantibody deposition (31) , secretory products of ectopic endometrial implants (32), iron overload (23) , scavenger receptor ligation (33) , bacterial endotoxin (34) , and altered sensitivity to ovarian steroids (3) . A plausible hypothesis is that in the context of endometriosis, a multiplicity of signals collectively contributes to a distinct macrophage activation phenotype. Such redundancy in upstream activation signals emphasizes the need to target regulatory nodes that control most of the downstream effectors with minimal compensatory modes to activation. Intriguingly, the observed secretion signature in our study exhibits characteristics of both prototypical classes of macrophage polarization, that is, marked IL-1b and IL-10 secretion (35) . Enrichment analysis of peritoneal aspirates did not support a distinct polarization phenotype among CD4 + lymphocyte subpopulations (Fig. 3A) . Conflicting evidence for T helper 1 (T H 1), T H 2, and T H 17 polarization in endometriosis have been reported (table S7) , but a clear consensus as to whether the unambiguous activity of innate leukocyte populations induces strongly polarized lymphocytes has yet to emerge.
Although our results clearly implicate a central role for macrophagedirected inflammation in both the progressive and debilitating characteristics of endometriosis, broader generalization of our findings may be modulated by selection biases with respect to demographic and clinical characteristics in any given study. For instance, the small number of patients in our reported study population represents a sampling of predominantly older women experiencing symptomatic disease. We anticipate that larger studies that facilitate increased sampling of young and asymptomatic patients across multiple practices may reveal additional or diverse consensus network signatures, or that studies of similar size in a practice with a different demographic may reveal a disparate single consensus signature. This may be expected if the disease state in an individual patient progresses through multiple stages characterized by different immunological networks at sequential times, or if different subsets of patients have alternative underlying disease processes despite similar morphological manifestations. Just as our consensus signature, when mapped back against clinical reports, was associated with particular clinical symptoms (reduced fertility), other signatures may map back to clinical correlations with pain or deep infiltrating disease. Indeed, we hope that this work stimulates further studies, perhaps international collaborative studies with large patient populations, to discern whether multiple dominant immune networks exist among different endometriosis patient subpopulations.
In summary, our data support the theory that pathogenic signatures of disease activity are present at diagnosis and that molecular profiling has the potential to improve outcome prediction across diverse endometriosis populations. Future studies from independent patient populations to replicate the consensus signature described herein or to define other signatures by similar analysis of different anatomical locations of disease impact may ultimately reveal a set of informative biological measurements that improve the efficacy of disease management.
MATERIALS AND METHODS

Study design
Sample size requirements were estimated by meta-analysis of 20 published reports describing significant molecular alterations in the peritoneal fluid of women surgically diagnosed with endometriosis (Supplementary Materials and Methods; fig. S1 ). Peritoneal fluid was obtained from 77 women undergoing laparoscopic surgery for nonmalignant gynecologic indications (endometriosis, adenomyosis, leiomyomata, menorrhagia, primary infertility, pelvic pain, hysterectomy, and/or elective sterilization). All participants provided informed consent in accordance with a protocol approved by the Partners Human Research Committee and the Massachusetts Institute of Technology Committee on the Use of Humans as Experimental Subjects. Study enrollment was limited to premenopausal women with regular cycles (26 to 35 days) and excluded patients with an irregular or ambiguous cycle history. In addition to electronic medical records documenting each patient's original consultation, preoperative visit, pathology report, and postoperative visit, all clinical data were documented using a standardized questionnaire. Abstracted clinical data were examined before laboratory analysis to establish each patient's eligibility and exclude patients with any concomitant indications of inflammatory disease (for example, autoimmune disorders, malignancy, or appendicitis). Inclusion of patients who reported use of progestin-based hormonal therapy within 3 months of surgery was limited to those with a concurrent diagnosis of endometriosis to evaluate the role of hormone suppression on inflammatory markers. Severity of endometriosis was visually scored according to the revised criteria of the ASRM (36) and classified as stage I/II (minimal/mild) or stage III/IV (moderate/severe) disease. Endometriosis was absent in 20 patients, whose samples served as disease-free controls. In all cases, atypical lesions were evaluated by histopathology to confirm the presence of endometriotic glands and stroma. All specimens were classified as luteal (days 1 to 14) or follicular (days 15 to 28) according to the donor's menstrual history. Severity of pain was characterized as absent/mild or moderate/severe.
Sample collection and processing
Peritoneal fluid was aspirated from the rectovaginal cul-de-sac immediately after trocar insertion and before peritoneal lavage or surgical manipulation. Specimens were placed immediately on ice, the volume and color were recorded, and 50 ml of primary aspirate was aliquoted for cytological characterization. The remaining volume was clarified within 15 min of collection by centrifugation for 10 min at 1000g. Clarified aspirates were transported to the laboratory on wet ice, aliquoted, and stored at −80°C until batch analysis. Peritoneal cell pellets were resuspended in phenol red-free Dulbecco's modified Eagle's medium/ F12 supplemented with 10% (v/v) dextran-charcoal-stripped fetal bovine serum, penicillin/streptomycin/amphotericin, and 10% (v/v) dimethyl sulfoxide (DMSO) before cryopreservation. Leukocyte and erythrocyte contents of the primary aspirate were determined by hemocytometer count. Total protein concentration was determined by bicinchoninic acid assay (Thermo Scientific Pierce) to identify and exclude saline-contaminated samples.
Multiplex cytokine immunoassays
Determination of 50 peritoneal cytokines, chemokines, and growth factors was performed using group I 27-plex, group II 21-plex, and ICAM-1 and VCAM-1 singleplex immunoassay panels according to the manufacturer's recommendations (Bio-Rad Laboratories). Prepared arrays were read with a Bio-Plex 200 system, and data were collected with Bio-Plex Manager Software. For VCAM-1 and ICAM-1, peritoneal aspirates were diluted 50-fold to bring the final analyte concentration within the linear detection range of the assay. All group I and II analytes were evaluated in neat, undiluted samples, and assays were performed in parallel (unmixed) to avoid antibody cross-reactivity between groups. Assay performance characteristics for each analyte are summarized in table S9. Median fluorescence intensity values were converted to absolute concentrations via calibration to a nine-point standard series.
Flow cytometry and cell culture Macrophage prevalence in peritoneal aspirates was assessed by flow cytometric quantitation of CD45 + /CD68 + leukocytes. For cytokine secretion assays, cryopreserved peritoneal leukocytes were rejuvenated in complete medium to recover mature adherent macrophages. After 2 hours of selective adhesion, nonadherent lymphocyte populations were removed by repeated washing, and fresh 1% serum-reduced medium was replaced for a 24-hour incubation period. Cytometric evaluation confirmed 90 to 95% CD68 + cells among cultures prepared by selective adherence (table S10) . Adherent CD68 + macrophages represented >85% of the total CD68 + pool present in peritoneal aspirates from both controls and endometriosis patients, and were shown to be the principal leukocyte population responsible for production of differentially secreted cytokines identified in culture medium ( fig. S5 ). To ensure that macrophages isolated from a select subset of samples were representative of the diverse peritoneal cytokine profiles while avoiding potential bias toward samples with low or high aspirate concentrations, cases for in vitro macrophage experiments (Figs. 3 and 5) were sampled from the 41 donors with equivalent proportional representation from the corresponding C1/C2 aspirate profiles (that is, a 5:3 ratio of C1/C2). For inhibitor experiments, vehicle (DMSO) or the indicated inhibitors were added to conditioning medium in replicate cultures to obtain a final concentration listed in table S11.
Data processing and statistical analysis Patient demographics and sample characteristics were evaluated by omnibus ANOVA, unpaired t test, Fisher's exact test, or multinomial logistic regression as indicated in Table 1 . Pairwise comparison of cytokine concentrations between populations stratified according to treatment status, ASRM staging, and cycle phase was evaluated by Wilcoxon rank-sum tests, and 95% CIs on test statistics were constructed via bootstrap. Significant associations were declared for cytokine associations achieving a two-sided P value < 0.05 after a Benjamini-Hochberg multiple testing correction. For multivariate analysis and heatmap visualization, cytokine concentrations were logtransformed and median-centered. Unsupervised classification of cytokine profiles into consensus clusters was carried out using NMF as described (14) . Class assignment stability was quantified by the cophenetic correlation coefficient for the co-occurrence matrix after 1000 randomly initialized factorizations. Reduced data sets evaluated by NMF were generated by sequentially eliminating cytokine markers exhibiting the smallest total variation. A multiple testing threshold (FDR < 0.05) for individual Wilcoxon rank-sum tests was similarly applied to determine cytokines discriminating NMF subpopulations C1 and C2. All statistical analysis was performed with MATLAB Statistics and Bioinformatics toolboxes.
Gene set enrichment and coexpression analysis GSEA was performed as described (37) using the IRIS [GES22886 (19) ] compendia to assess enrichment for cytokine production across resting and activate immune cell lineages. To accommodate incomplete measurement of all known secreted gene products, statistical significance of phenotype enrichment scores was computed using a null distribution of enrichment scores corresponding to randomly generated cytokine signatures of identical size from the list of 47 assayed proteins. Pairwise enrichment for coordinated cytokine ligand and receptor expression between lineages was similarly calculated using a two-dimensional enrichment statistic to identify overrepresented intercellular interactions. Directed edges between lineages were constructed for scores attaining significance (P < 0.05), and nodes were arranged hierarchically in order of decreasing out-degree. Table S1 . Pairwise Wilcoxon rank-sum tests-treatment status. Table S2 . Pairwise Wilcoxon rank-sum tests-ASRM staging. Table S3 . Pairwise Wilcoxon rank-sum tests-cycle phase. Table S4 . Pairwise Wilcoxon rank-sum tests-recurrence status. Table S5 . Pairwise Wilcoxon rank-sum tests-lesion distribution. Table S6 . Pairwise Wilcoxon rank-sum tests-primary indication. Table S7 . Reported associations between peritoneal cytokines, chemokines, growth factors, and pelvic endometriosis. Table S8 . Overrepresented transcriptional binding sites among macrophage-secreted cytokines. Table S9 . Luminex targets and assay performance characteristics. Table S10 . Leukocyte subpopulations among peritoneal aspirates. Table S11 . Kinase inhibitor treatments. Reference (39) 
